CRISPR Cas9

BIRSA 101: INDIA'S INDIGENOUS CRISPR THERAPY FOR SICKLE CELL DISEASE

Union Government launched BIRSA 101, India's first indigenous CRISPR gene therapy targeting Sickle Cell Disease. Developed by CSIR-IGIB and SII, this affordable enFnCas9 technology primarily benefits tribal communities, accelerating the National Sickle Cell Elimination Mission 2047